Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets(TM)

Source :: PR Newswire. March 15, 2024
Publication Year :: 2024
Abstract: CHICAGO, March 15, 2024 /PRNewswire/ --https://www.marketsandmarkets.com/Market-Reports/monoclonal-antibody-mabs-therapeutics-market-115323820.html?utm_source=Prnewswire&utm_medium=referral&utm_campaign=paidpr in terms of revenue was estimated to be worth $252.6 billion in 2024 and is poised to reach $497.5 billion by 2029, growing at [...]

Subjects :: Merck & Company Inc. -- Forecasts and trends
Amgen Inc. -- Forecasts and trends
Johnson & Johnson -- Forecasts and trends
AbbVie Inc. -- Forecasts and trends
Bristol-Myers Squibb Co. -- Forecasts and trends
Eli Lilly and Co. -- Forecasts and trends
Biotechnology industry -- Forecasts and trends -- Statistics
Adalimumab -- Statistics
Pharmaceutical industry -- Statistics -- Forecasts and trends
Market trend/market analysis
Business
News, opinion and commentary

Tools